LAMEA Cancer Immunotherapy Market Analysis (2017-2023)

  • ID: 4456899
  • Report
  • 84 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • MORE
The LAMEA Cancer Immunotherapy Market would witness market growth of 17.9% CAGR during the forecast period (2017 - 2023). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.

The key factors driving the growth of cancer immunotherapy market are rising incidence and prevalence of cancer, technologically advanced treatment therapies, Growing R&D activities to treat cancer, and specificity & effectiveness of cancer immunotherapy for the treatment of wide range of cancers such as lung cancer, breast cancer, skin cancer, and others. Also, growing healthcare expenditure and better healthcare insurance coverage would further add to the market growth during the analysis period. Nevertheless, lack of professional healthcare experts and limited awareness about possible solutions among the population are the factors that limit the growth..

Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology. End user is segmented into Polymeric Coatings and Organic Coatings. The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Other Cancer. The report also covers geographical segmentation of Cancer Immunotherapy market. The report also covers country wise segmentation of Cancer Immunotherapy market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Cancer Immunotherapy Market. Key companies profiled in the report include Novartis Ag, Astrazeneca Plc., Amgen Inc., Immunomedics, Inc., Bayer Ag, Pfizer Inc., Bristol-Myers Squibb, Merck Sharp & Dohme Corp., Eli Lilly And Company, and F. Hoffmann-La Roche Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cancer Immunotherapy Market, by Technology
1.4.2 LAMEA Cancer Immunotherapy Market, by Application
1.4.3 LAMEA Cancer Immunotherapy Market, by End User
1.4.4 LAMEA Cancer Immunotherapy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Cancer Immunotherapy Market
3.1 LAMEA Cancer Immunotherapy Market by Technology
3.1.1 LAMEA Monoclonal Antibodies Cancer Immunotherapy Market by Country
3.1.2 LAMEA Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
3.1.3 LAMEA Other Technology Cancer Immunotherapy Market by Country

Chapter 4. LAMEA Cancer Immunotherapy Market by End User
4.1 Introduction
4.1.1 LAMEA Hospitals Cancer Immunotherapy Market by Country
4.1.2 LAMEA Clinics & Others Cancer Immunotherapy Market by Country

Chapter 5. LAMEA Cancer Immunotherapy Market by Application
5.1.1 LAMEA Cancer Immunotherapy in Lung Cancer Market by Country
5.1.2 LAMEA Cancer Immunotherapy in Breast Cancer Market by Country
5.1.3 LAMEA Cancer Immunotherapy in Colorectal Cancer Market by Country
5.1.4 LAMEA Cancer Immunotherapy in Melanoma Market by Country
5.1.5 LAMEA Cancer Immunotherapy in Prostate Cancer Market by Country
5.1.6 LAMEA Cancer Immunotherapy in Head & Neck Cancer Market by Country
5.1.7 LAMEA Cancer Immunotherapy in Other Application Market by Country

Chapter 6. LAMEA Cancer Immunotherapy Market by Country
6.1 Introduction
6.2 Brazil Cancer Immunotherapy Market
6.2.1 Brazil Cancer Immunotherapy Market by Technology
6.2.2 Brazil Cancer Immunotherapy Market by End User
6.2.3 Brazil Cancer Immunotherapy Market by Application
6.3 Argentina Cancer Immunotherapy Market
6.3.1 Argentina Cancer Immunotherapy Market by Technology
6.3.2 Argentina Cancer Immunotherapy Market by End User
6.3.3 Argentina Cancer Immunotherapy Market by Application
6.4 UAE Cancer Immunotherapy Market
6.4.1 UAE Cancer Immunotherapy Market by Technology
6.4.2 UAE Cancer Immunotherapy Market by End User
6.4.3 UAE Cancer Immunotherapy Market by Application
6.5 Saudi Arabia Cancer Immunotherapy Market
6.5.1 Saudi Arabia Cancer Immunotherapy Market by Technology
6.5.2 Saudi Arabia Cancer Immunotherapy Market by End User
6.5.3 Saudi Arabia Cancer Immunotherapy Market by Application
6.6 South Africa Cancer Immunotherapy Market
6.6.1 South Africa Cancer Immunotherapy Market by Technology
6.6.2 South Africa Cancer Immunotherapy Market by End User
6.6.3 South Africa Cancer Immunotherapy Market by Application
6.7 Nigeria Cancer Immunotherapy Market
6.7.1 Nigeria Cancer Immunotherapy Market by Technology
6.7.2 Nigeria Cancer Immunotherapy Market by End User
6.7.3 Nigeria Cancer Immunotherapy Market by Application
6.8 Rest of LAMEA Cancer Immunotherapy Market
6.8.1 Rest of LAMEA Cancer Immunotherapy Market by Technology
6.8.2 Rest of LAMEA Cancer Immunotherapy Market by End User
6.8.3 Rest of LAMEA Cancer Immunotherapy Market by Application

Chapter 7. Company Profiles
7.1 Novartis AG
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Astrazeneca Plc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.3 Amgen Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Immunomedics, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Pfizer Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Bristol-Myers Squibb
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Merck Sharp & Dohme Corp.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Eli Lilly and Company
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.1 F. Hoffmann-La Roche Ltd
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Astrazeneca Plc.
  • Amgen Inc.
  • Immunomedics, Inc.
  • Bayer AG
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll